During the past decade, Austin Cancer Centers-Northwest conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Austin Cancer Centers-Northwest" #1 collaborator was "National Cancer Institute (NCI)" with 2 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Canadian Cancer Trials Group" with 1 trials as a collaborator and "United States Department of Defense" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Austin Cancer Centers-Northwest" are "Estrogen Receptor-positive Breast Cancer" (1 trials), "HER2-negative Breast Cancer" (1 trials), "Invasive Ductal Breast Carcinoma" (1 trials), "Invasive Lobular Breast Carcinoma" (1 trials) and "Node Positive HER2 Negative Breast Cancer" (1 trials). Many other conditions were trialed in "Austin Cancer Centers-Northwest" in a lesser frequency.

Most popular intervention types in "Austin Cancer Centers-Northwest" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Aspirin" (1 trials), "Placebo" (1 trials), "anastrozole" (1 trials) and "fulvestrant" (1 trials). Other intervention names were less common.

The vast majority of trials in "Austin Cancer Centers-Northwest" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Austin Cancer Centers-Northwest". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Austin Cancer Centers-Northwest, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Austin Cancer Centers-Northwest, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".